Cargando…
DNA-damaging cancer cells to improve virotherapy
Autores principales: | Garcia-Moure, Marc, Tallon-Cobos, Antonio Carlos, Alonso, Marta M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593301/ https://www.ncbi.nlm.nih.gov/pubmed/36321133 http://dx.doi.org/10.1016/j.omto.2022.10.002 |
Ejemplares similares
-
IMMU-18. Targeting Antigen Presenting Cells to improve virotherapy efficacy in Diffuse Midline Gliomas
por: Labiano, Sara, et al.
Publicado: (2022) -
Oncolytic virotherapy meets the human organoid technology for pancreatic cancers
por: Fiorini, Elena, et al.
Publicado: (2020) -
Oncolytic virotherapy targeting the IL15 pathway
por: Yoo, So Young, et al.
Publicado: (2023) -
Virotherapy in Cancer
por: Motalleb, Gholamreza
Publicado: (2013) -
Tumour microenvironment: Modulating effects, challenges, and future perspectives of oncolytic virotherapy in Astrocytoma treatment
por: Awuah, Wireko Andrew, et al.
Publicado: (2022)